companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2020

CVR: 20045078

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 353,314,000 and a net result of DKK -846,729,000 compared with DKK -571,541,000 the year before. That is an increase of 754.8% compared with the year before. The profit margin was -239.7%. Equity in the 2020 report amounted to DKK 1,229,311,000. The solvency ratio was 69.8%. The company had 297 employees in the financial year.

Revenue
DKK 353,314,000
Gross Profit
DKK 262,749,000
Profit/Loss
DKK -846,729,000
Equity
DKK 1,229,311,000
Total Assets
DKK 1,761,949,000
Employees
297

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020353.3M262.7M-846.7M1.2B297
201941.3M--571.5M1.2B-
201838M-581.3M1.1B-
2017139.8M--272.3M528.5M-
2016234.8M--153.9M278.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ZEALAND PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ZEALAND PHARMA A/S publishes interim reportAug 24, 2020

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 to June 30, 2020.

ZEALAND PHARMA A/S publishes interim reportAug 13, 2020

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2020 to March 31, 2020.

ZEALAND PHARMA A/S: The 2019 annual report is outApr 8, 2020

ZEALAND PHARMA A/S has published its annual report for 2019. Revenue came to DKK 41,333,000, and the net result was DKK -571,541,000.

ZEALAND PHARMA A/S appoints new auditorApr 2, 2020

As of April 2, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZEALAND PHARMA A/S.

Auditor steps down at ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZEALAND PHARMA A/S.

Gertrud Koefoed Rasmussen joins the board of ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, Gertrud Koefoed Rasmussen has joined the board of directors of ZEALAND PHARMA A/S.

Jacob Ulrik Fog joins the board of ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, Jacob Ulrik Fog has joined the board of directors of ZEALAND PHARMA A/S.

Nikolaj Frederik Beck joins the board of ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, Nikolaj Frederik Beck has joined the board of directors of ZEALAND PHARMA A/S.

Iben Louise Gjelstrup joins the board of ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, Iben Louise Gjelstrup has joined the board of directors of ZEALAND PHARMA A/S.

Hanne Heidenheim Bak leaves the board of ZEALAND PHARMA A/SApr 2, 2020

As of April 2, 2020, Hanne Heidenheim Bak has left the board of directors of ZEALAND PHARMA A/S.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority